hydralazine has been researched along with digoxin in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (46.15) | 18.7374 |
1990's | 7 (13.46) | 18.2507 |
2000's | 11 (21.15) | 29.6817 |
2010's | 10 (19.23) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Markenson, JA; Sherman, RL | 1 |
Black, JR; Mehta, J | 1 |
Campbell, TJ | 1 |
Crawford, MH; O'Rourke, RA; Vittitoe, JA; Wilson, RS | 1 |
Vine, DL | 1 |
Elkayam, U; Frishman, WH; Rubin, JN; Widerhorn, J | 1 |
Guyatt, GH | 1 |
Alderman, MH; Marantz, PR; Tobin, JN | 1 |
Halawa, B; Mazurek, W | 1 |
Lesch, M; Ribner, HS; Stadnicki, R; Stasior, C; Talentowski, D; Zucker, MJ | 1 |
Mehta, NC; Patel, HR; Patel, KH; Shah, CP; Thorat, PB | 1 |
Fedotenkov, SA; Pomerantsev, VP; Vasiuk, IuA | 1 |
Arriagada, D; Casanegra, P; Chamorro, G; Corbalán, R; Meleda, I; Rodríguez, JA; Valenzuela, P | 1 |
Friedman, WF; George, BL | 1 |
Artman, M; Graham, TP; Parrish, MD | 1 |
Beekman, RH; Crowley, DC; Dick, M; Rocchini, AP; Rosenthal, A | 1 |
Chuck, LH; Hollosi, G; Kidd, P; Parmley, WW; Rouleau, JL; Sievers, RE; Wikman-Coffelt, J | 1 |
Conradson, TB; Rydén, L | 1 |
Kothiala, A; Mehta, NC; Patel, HR; Ramnani, K; Shah, CP | 1 |
Greenberg, BH; Rahimtoola, SH | 1 |
Parmley, WW; Rapcsak, M; Rouleau, JL; Sievers, R; Wikman-Coffelt, J | 1 |
Bussey, HI | 1 |
Jain, A; Nicolle, FI; Sanders, CV | 1 |
Benowitz, NL; Carlson, CJ; Cogan, JJ; Humphreys, MH; Rapaport, E | 1 |
Whiting, RB | 1 |
Giles, TD | 1 |
Baker, DW; Bottorff, M; Konstam, MA; Pitt, B | 1 |
King, D | 1 |
Adams, KF; Ellis, ML; Patterson, JH; Williamson, KM | 1 |
Struthers, AD | 1 |
Takahashi, M; Uehara, Y | 1 |
Harjai, KJ; Newman, J; Nunez, E; Shah, M; Stewart Humphrey, J; Turgut, T | 1 |
Aronow, WS | 1 |
Rich, MW | 1 |
Gould, PA; Kaye, DM | 1 |
Bove, T; Crivellari, M; Landoni, G; Zangrillo, A | 1 |
Hsich, EM; Piña, IL | 1 |
Lim, WY; Woldman, S | 1 |
Eisen, HJ; Feitell, S; Hankins, SR | 1 |
Colvin-Adams, M; Sharma, A; Yancy, CW | 1 |
Enseleit, F; Flammer, AJ; Naegele, M; Ruschitzka, F | 1 |
Adhyaru, B; Raj, L | 1 |
Wu, A | 1 |
19 review(s) available for hydralazine and digoxin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cardiovascular drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiovascular Agents; Digoxin; Female; Humans; Hydralazine; Nitrates; Nitroprusside; Pregnancy; Pregnancy Complications, Cardiovascular | 1987 |
The treatment of heart failure. A methodological review of the literature.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Digoxin; Diuretics; Heart Diseases; Humans; Hydralazine; Nitrates; Piperazines; Prazosin; Pyridines; Research Design | 1986 |
Diagnostic heterogeneity in clinical trials for congestive heart failure.
Topics: Amrinone; Clinical Trials as Topic; Digoxin; Heart Failure; Humans; Hydralazine; Metoprolol; Research Design | 1988 |
Congestive heart failure in childhood and adolescence: recognition and management.
Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Electrocardiography; Endocarditis, Bacterial; Furosemide; Heart; Heart Defects, Congenital; Heart Diseases; Heart Failure; Humans; Hydralazine; Isoproterenol; Nitroprusside; Physical Examination; Radionuclide Imaging; Rheumatic Heart Disease | 1983 |
Optimizing the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume | 1994 |
Management of heart failure. I. Pharmacologic treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Decision Support Techniques; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; United States; United States Agency for Healthcare Research and Quality; Ventricular Dysfunction, Left | 1994 |
Diagnosis and management of heart failure in the elderly.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Digoxin; Diuretics; Female; Heart Failure; Humans; Hydralazine; Isosorbide; Male; Middle Aged; Prognosis; Vasodilator Agents | 1996 |
Rationalizing the heart failure trials: from theory to practice.
Topics: Adrenergic beta-Antagonists; Amiodarone; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Blood Pressure; Clinical Trials as Topic; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Treatment Outcome; Vasodilator Agents | 1997 |
Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Topics: Adrenergic beta-Antagonists; Aged; Aging; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Diagnosis, Differential; Diastole; Digoxin; Diuretics; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Prevalence; Prognosis; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke Volume; Ventricular Dysfunction, Left | 2001 |
Management of heart failure in the elderly.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Patient Education as Topic; Self Care | 2002 |
Clinical treatment regimens for chronic heart failure: a review.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiotonic Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Pacemaker, Artificial; Spironolactone; Vasodilator Agents | 2002 |
Heart failure in women: a need for prospective data.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiac Pacing, Artificial; Digoxin; Female; Heart Failure; Heart-Assist Devices; Humans; Hydralazine; Isosorbide Dinitrate; Male; Mineralocorticoid Receptor Antagonists; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Risk Factors; Sex Factors; Women's Health | 2009 |
Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Digoxin; Drug Combinations; Heart Failure; Heart Failure, Systolic; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists | 2013 |
Adjunctive therapy and management of the transition of care in patients with heart failure.
Topics: Adaptation, Psychological; Adrenergic beta-Antagonists; Alcohol Drinking; Ambulatory Care; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Resynchronization Therapy; Cardiotonic Agents; Continuity of Patient Care; Defibrillators, Implantable; Deinstitutionalization; Diet; Digoxin; Diuretics; Drug Combinations; Exercise Therapy; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Mineralocorticoid Receptor Antagonists; Palliative Care; Risk Reduction Behavior; Secondary Prevention; Self Care; Smoking Cessation; Substance-Related Disorders | 2014 |
Heart failure in African Americans: disparities can be overcome.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Cardiotonic Agents; Defibrillators, Implantable; Digoxin; Drug Combinations; Health Status Disparities; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Hydralazine; Hypertension; Incidence; Isosorbide Dinitrate; Mineralocorticoid Receptor Antagonists; Prevalence; Quality of Health Care; Socioeconomic Factors; Vasodilator Agents | 2014 |
Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Stroke Volume; Vasodilator Agents | 2016 |
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents | 2016 |
Heart Failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors | 2018 |
2 trial(s) available for hydralazine and digoxin
Article | Year |
---|---|
Effect of digoxin and vasodilators on left ventricular function in aortic regurgitation.
Topics: Adult; Analysis of Variance; Aortic Valve Insufficiency; Digoxin; Echocardiography; Exercise Test; Heart Ventricles; Humans; Hydralazine; Male; Middle Aged; Nifedipine; Stroke Volume | 1989 |
The treatment of heart failure. A methodological review of the literature.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Clinical Trials as Topic; Digoxin; Diuretics; Heart Diseases; Humans; Hydralazine; Nitrates; Piperazines; Prazosin; Pyridines; Research Design | 1986 |
32 other study(ies) available for hydralazine and digoxin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Renal involvement in progressive systemic sclerosis: prolonged survival with aggressive antihypertensive management.
Topics: Adult; Antihypertensive Agents; Cardiomegaly; Digoxin; Drug Therapy, Combination; Female; Furosemide; Humans; Hydralazine; Hypertension, Malignant; Hypertension, Renal; Kidney Diseases; Methyldopa; Minoxidil; Propranolol; Scleroderma, Systemic; Time Factors | 1979 |
Precipitation of heart failure following sudden withdrawal of hydralazine.
Topics: Administration, Oral; Aged; Aortic Valve Insufficiency; Digoxin; Furosemide; Heart Failure; Hemodynamics; Humans; Hydralazine; Hypoxia, Brain; Injections, Intravenous; Male; Neurocognitive Disorders; Nitroprusside; Substance Withdrawal Syndrome; Vascular Resistance | 1979 |
Recent developments in the pharmacotherapy of cardiac failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Digoxin; Diuretics; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hydralazine; Vasodilator Agents | 1992 |
Digitalis for patients with heart failure.
Topics: Digitalis; Digoxin; Heart Failure; Humans; Hydralazine; Plants, Medicinal; Plants, Toxic | 1989 |
[Interaction of digoxin with hydralazine and prazosin].
Topics: Adult; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prazosin | 1986 |
Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
Topics: Aged; Digoxin; Drug Combinations; Exercise Test; Heart Failure; Hemodynamics; Humans; Hydralazine; Infusions, Intravenous; Male; Middle Aged; Rest; Vasodilator Agents | 1987 |
Comparative efficacy of digoxin, hydralazine and combination therapy in chronic congestive heart failure.
Topics: Adult; Chronic Disease; Digoxin; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Male; Prospective Studies | 1986 |
[Effect of digoxin, apressin and nitrosorbide on the hemodynamics in patients after myocardial infarction].
Topics: Adult; Aged; Digoxin; Ferricyanides; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Infarction; Nitroprusside | 1986 |
[Long-term effects of digoxin and hydralazine in patients with chronic cardiac insufficiency].
Topics: Adult; Aged; Chronic Disease; Digoxin; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Hydralazine; Male; Middle Aged; Stroke Volume | 1985 |
Treatment of congestive heart failure by altering loading conditions of the heart.
Topics: Captopril; Cardiac Output; Child; Digoxin; Dopamine; Drug Therapy, Combination; Heart; Heart Failure; Humans; Hydralazine; Infant; Infant, Newborn; Nitroglycerin; Nitroprusside; Prazosin; Vasodilator Agents | 1985 |
Vasodilator therapy in children: acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation.
Topics: Adolescent; Captopril; Cardiac Catheterization; Child; Child, Preschool; Digoxin; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Infant; Mitral Valve Insufficiency; Prazosin; Time Factors; Vasodilator Agents | 1984 |
Verapamil preserves myocardial contractility in the hereditary cardiomyopathy of the Syrian hamster.
Topics: Actins; Adenosine Triphosphatases; Animals; Cardiomyopathies; Cricetinae; Digoxin; Hydralazine; Mesocricetus; Myocardial Contraction; Myocardium; Myosins; Papillary Muscles; Sodium Chloride; Verapamil | 1982 |
Improved cardiac performance during exercise following hydralazine treatment in chronic heart failure.
Topics: Aged; Chronic Disease; Digoxin; Diuretics; Exercise Test; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Physical Exertion | 1984 |
Adjuvant therapy of chronic refractory cardiac failure with oral hydralazine and isosorbide dinitrate.
Topics: Administration, Oral; Adolescent; Adult; Aged; Chronic Disease; Digoxin; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents | 1983 |
Usefulness of vasodilator therapy in acute and chronic valvular regurgitation.
Topics: Aortic Valve; Aortic Valve Insufficiency; Combined Modality Therapy; Digoxin; Drug Therapy, Combination; Heart Failure; Heart Valve Prosthesis; Hemodynamics; Humans; Hydralazine; Mitral Valve; Mitral Valve Insufficiency; Nitroprusside; Vasodilator Agents | 1984 |
Verapamil, propranolol, and hydralazine protect against the acute cardiac depression induced by adriamycin.
Topics: Animals; Depression, Chemical; Digoxin; Doxorubicin; Heart; Hemodynamics; Hydralazine; In Vitro Techniques; Myocardial Contraction; Perfusion; Propranolol; Rats; Rats, Inbred Strains; Verapamil | 1983 |
Tolerance to hydralazine in congestive heart failure.
Topics: Digoxin; Drug Tolerance; Heart Failure; Humans; Hydralazine | 1982 |
Drug fever during treatment of pulmonary edema.
Topics: Aminophylline; Blood Pressure; Digoxin; Fever; Furosemide; Humans; Hydralazine; Male; Methyldopa; Middle Aged; Pulmonary Edema | 1982 |
Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure.
Topics: Chronic Disease; Digoxin; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Hydralazine; Kidney; Metabolic Clearance Rate; Middle Aged; Nitroprusside; Renal Circulation; Vasodilator Agents | 1981 |
Systolic time intervals. Noninvasive assessment of vasodilator therapy for congestive failure.
Topics: Adult; Digoxin; Echocardiography; Electrocardiography; Furosemide; Heart Failure; Humans; Hydralazine; Male; Myocardial Contraction; Systole; Vasodilator Agents | 1981 |
The AHCPR clinical practice guideline for heart failure revisited.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Calcium Channel Blockers; Cardiac Output, Low; Digoxin; Diuretics; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Ventricular Dysfunction, Left | 1997 |
Hemodynamic changes during administration of drugs for mitral regurgitation in dogs.
Topics: Animals; Captopril; Cardiotonic Agents; Digoxin; Dog Diseases; Dogs; Echocardiography, Doppler, Color; Enalapril; Hemodynamics; Hydralazine; Mitral Valve Insufficiency; Prazosin; Vasodilator Agents | 1998 |
Does gender bias exist in the medical management of heart failure?
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiology; Cardiotonic Agents; Caregivers; Data Interpretation, Statistical; Digoxin; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Male; Middle Aged; Odds Ratio; Prejudice; Vasodilator Agents | 2000 |
Heart failure after Caesarean section for twin delivery.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Cardiotonic Agents; Catheterization, Swan-Ganz; Cesarean Section; Diagnosis, Differential; Digoxin; Diuretics; Dobutamine; Electrocardiography; Female; Furosemide; Heart Failure; Humans; Hydralazine; Intubation, Intratracheal; Nitroprusside; Pulmonary Edema; Twins; Vasodilator Agents | 2004 |